Whilst ENO1 is originally identified as a critical glycolytic enzyme whose expression is upregulated in malignant tumors (29), like many metabolic enzymes, ENO1 evolves other cellular functions independent of its glycolytic function. The gene discussed is ENO1; the disease is cancer.